Drug Discovery Market Research Reports & Industry Analysis

Drug discovery is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will actually yield products that achieve regulatory approval by the Food & Drug Administration (FDA). The average drug can take 10+ years to progress from the discovery phase to the clinic, with only one compound out of 10,000 evolving into a viable product. Need for discovery is driven by the need for new products to market and sell. The number of new pharmaceuticals introduced to the market has dropped precipitously in recent years but has been on a downward trend for over a decade. At a time when basic biomedical knowledge is increasing exponentially, the gap between bench discovery and new pharmaceuticals appears to be expanding.

Through outsourcing portions of their drug discovery programs, many pharmaceutical and biotechnology companies have found an effective cost-cutting strategy that can also improve the hit-to-lead conversion and early identification of unsuccessful compounds. In view of the fact that outsourcing can accelerate the drug discovery process, the business of contract drug discovery has evolved from providing low-end research services to more value-added high-end research.

...Show More ...Show Less


Drug Discovery Industry Research & Market Reports

  • HIV Diagnostics Market

    ... for 2022-2032. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum ... Read More

  • Mental Illness Drugs Markets in China

    ... The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines ... Read More

  • Central Nervous System Disorder Drugs Markets in China

    ... will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. ... Read More

  • Central Nervous System Disorder Drugs Industry Forecasts - China Focus

    ... fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far ... Read More

  • Pneumonia Treatment Drugs Industry Forecasts - China Focus

    ... expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in ... Read More

  • Hypertension Drugs Markets in China

    ... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic ... Read More

  • Anti-Obesity Drugs Markets in China

    ... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic ... Read More

  • Blood Disease Drugs Markets in China

    ... The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines ... Read More

  • Anti-Tumor Drugs Markets in China

    ... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic ... Read More

  • Lymphoma Treatment Drugs Markets in China

    ... The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines ... Read More

  • Anti-Tumor Drugs Industry Forecasts - China Focus

    ... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ... Read More

  • Incretion Drugs Industry Forecasts - China Focus

    ... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ... Read More

  • Bipolar Disorder Therapeutics

    ... year 2020, is projected to reach a revised size of US$6.9 Billion by 2027, growing at a CAGR of 3.1% over the analysis period 2020-2027. Antipsychotic Drugs, one of the segments analyzed in the report, ... Read More

  • Acute Myeloid Leukemia (AML) Therapeutics

    ... estimated at US$476.9 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at a CAGR of 12.6% over the analysis period 2020-2027. Cytarabine, one of the ... Read More

  • Cancer Cachexia

    ... projected to reach a revised size of US$2.9 Billion by 2027, growing at a CAGR of 4.7% over the analysis period 2020-2027. Progestogens, one of the segments analyzed in the report, is projected to record ... Read More

  • Botulinum Toxin

    ... projected to reach a revised size of US$8.5 Billion by 2027, growing at aCAGR of 8.2% over the period 2020-2027. Type A, one of the segments analyzed in the report, is projected to record 8.2% ... Read More

  • COVID-19 Vaccines

    ... of annual doses in China is forecast to stabilize to US$23 billion by 2025, after peaking at US$73 billion in the year 2021. Global percentage of individuals vaccinated by the year 2025 is expected to ... Read More

  • Global Coronavirus Partnering 2015-2022

    ... deal terms for headline, upfront and royalty by stage of development Coronavirus partnering agreement structure Coronavirus partnering contract documents Top Coronavirus deals by value Most active Coronavirus dealmakers Most of the deals included within the ... Read More

  • Label-Free Detection

    ... need for labelling of the analyte. Although an evolving and unproven technology, label-free detection is growing in popularity as an excellent research and general purpose analytical tool. Label-free detection utilizes optical, electrical, acoustic, signal intensity, ... Read More

  • Drug Discovery Technologies

    ... year 2020, is projected to reach a revised size of US$85.9 Billion by 2027, growing at aCAGR of 8.1% over the period 2020-2027. Small Molecule Drugs, one of the segments analyzed in the report, is ... Read More

  • ADME-Toxicology Testing

    ... projected to reach a revised size of US$12.3 Billion by 2027, growing at a CAGR of 10.9% over the analysis period 2020-2027. Cell Culture, one of the segments analyzed in the report, is projected to ... Read More

  • Osteoporosis Therapeutics

    ... bone architecture, resulting in increased risk of fractures. Afflicting more than 200 million people worldwide, the potentially life-threatening disease - osteoporosis poses a major clinical challenge to the medical world. Osteoporosis therapeutics are mainly targeted ... Read More

  • Synthetic Biology

    ... projected to reach a revised size of US$36 Billion by 2027, growing at a CAGR of 28.1% over the analysis period 2020-2027. Oligonucleotides & Synthetic DNA, one of the segments analyzed in the report, is ... Read More

  • HER-2 Negative Breast Cancer Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

    ... USD 20.442.3 million by 2027, registering a CAGR of 10.08% over the forecast period. The emergence of the COVID-19 pandemic had an adverse effect on the world economy and healthcare system. The lockdown all over ... Read More

  • Crohn’s Disease Therapeutics Market Forecast - Epidemiology & Pipeline Analysis

    ... disease (IBD) that causes digestive tract inflammation, leading to abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition. The inflammatory bowel disease treatment market can be segmented into two types, i.e., Crohn's Disease and Ulcerative ... Read More

< prev 1 2 3 4 5 6 7 8 9 10

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings